| Company Name: |
Shanghai Kewel Chemical Co., Ltd.
|
| Tel: |
021-64609169 18901607656 |
| Email: |
greensnown@163.com |
| Products Intro: |
Product Name:Abiraterone Impurity 31
CAS:186826-68-6
Purity:95+ HPLC; Package:10mg;25mg;50mg;100mg
|
| Company Name: |
Roark Standards
|
| Tel: |
0755-83552066 15986688328 |
| Email: |
service@roarkstandards.com |
| Products Intro: |
Product Name:Abiraterone Acetate Dimer Impurity
CAS:186826-68-6
Purity:98% HPLC Package:10MG;25MG;50MG;100MG
|
| Company Name: |
Shenzhen Botel Biotechnology Co. Ltd.
|
| Tel: |
13316949107 13316968096 |
| Email: |
1979313431@qq.com |
| Products Intro: |
Product Name:(3β)-16-[(3β)-3-(Acetyloxy)androsta-5,16-dien-17-yl]-17-(3-pyridinyl)-androsta-5,16-dien-3-ol 3-Acetate
CAS:186826-68-6
Purity:>95% HPLC Package:10mg,25mg,50mg,100mg；品牌：PLC
|
|
| | Abiraterone Acetate Dimer Impurity Basic information |
| Product Name: | Abiraterone Acetate Dimer Impurity | | Synonyms: | (3β)-16-[(3β)-3-(Acetyloxy)androsta-5,16-dien-17-yl]-17-(3-pyridinyl)-androsta-5,16-dien-3-ol 3-Acetate;Abiraterone Impurity 31;)-16-[(3β)-3-(Acetyloxy)androsta-5,16-dien-17-yl]-17-(3-pyridinyl)-androsta-5,16-dien-3-ol3-Acetate;Androsta-5,16-dien-3-ol, 16-[(3β)-3-(acetyloxy)androsta-5,16-dien-17-yl]-17-(3-pyridinyl)-, 3-acetate, (3β)-;Abiraterone Acetate DimerQ: What is
Abiraterone Acetate Dimer Q: What is the CAS Number of
Abiraterone Acetate Dimer;(3beta)-16-[(3beta)-3-(Acetyloxy)androsta-5,16-dien-17-yl]-17-(3-pyridinyl)-androsta-5,16-dien-3-ol 3-Acetate | | CAS: | 186826-68-6 | | MF: | C47H61NO4 | | MW: | 704.01 | | EINECS: | | | Product Categories: | | | Mol File: | 186826-68-6.mol |  |
| | Abiraterone Acetate Dimer Impurity Chemical Properties |
| density | 1.17±0.1 g/cm3(Predicted) | | pka | 5.31±0.12(Predicted) |
| | Abiraterone Acetate Dimer Impurity Usage And Synthesis |
| Uses | (3β)-16-[(3β)-3-(Acetyloxy)androsta-5,16-dien-17-yl]-17-(3-pyridinyl)-androsta-5,16-dien-3-ol 3-Acetate is a derivative of Abiraterone (A108490), which is a steroidal cytochrome P 450 17α-hydroxylase-17,20-lyase inhibitor (CYP17), is currently undergoing phase II clinical trials as a potential drug for the treatment of androgen-dependent prostate cancer. |
| | Abiraterone Acetate Dimer Impurity Preparation Products And Raw materials |
|